{
    "2019-04-23": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie's Skyrizi drug to treat psoriasis wins U.S. approval",
                "features": {
                    "keywords": [
                        "Skyrizi",
                        "psoriasis",
                        "U.S. approval"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie stock ticks higher on FDA approval of psoriasis treatment",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA approval",
                        "psoriasis"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI™ (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Immunology",
                        "FDA Approval",
                        "SKYRIZI",
                        "Moderate to Severe Plaque Psoriasis"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "You can find plenty of solid stock bargains in this year’s worst-performing sector, analyst says",
                "features": {
                    "keywords": [
                        "solid stock bargains",
                        "worst-performing sector"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Analysts see plenty of attractive bargains in this year’s worst-performing stock sector",
                "features": {
                    "keywords": [
                        "attractive bargains",
                        "worst-performing stock sector"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}